FORTIS HEALTHCARE LTD. - 532843 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 072720 Name of the Signatory :- Sumit GoelDesignation :- Company Secretary and Compliance Officer Chart Focus: Fortis Healthcare (139.6) - Buy
The Fortis Healthcare stock has been witnessing buying interest over the past three weeks and has surged 12 per cent in this period. It has the poten Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Change in Directorate
In compliance of Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that Board of Directors of the Company has approved appointment of Dr. Kelvin Loh Chi-Keon (DIN:08515101) as an additional director (Non-Executive and Non-Independent) of the Company with immediate effect. He will hold the office up to the next Annual General Meeting and will be regularized subject to the approval of the shareholders. He is not related to any of the existing directors. Brief Profile of Dr. Loh is attached herewith and marked as Annexure 1. Dr. Loh declared that, he is not debarred from accessing the capital markets and / or restrained from holding any position / office of director in a company pursuant to order of SEBI or any other such authority. Further, Dr. See Leng Tan, Non-Executive Director of the Company, has resigned from directorship of the Company effective from September 27, 2019. FORTIS HEALTHCARE LTD. - 532843 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Fortis Healthcare Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here FORTIS HEALTHCARE LTD. - 532843 - Closure of Trading Window
With reference to the provisions of Policy / Code of Conduct for Prevention of Insider Trading, the "Trading Window" for dealing in shares of the Company is closed from September 30, 2019 till 48 hours of declaration of results for the quarter and period ending on September 30, 2019. This is for your information and records please. Fortis Healthcare Ltd - 532843 - Summary Of Proceedings Of The 23Rd Annual General Meeting
It is hereby informed that 23rd Annual General Meeting ('AGM') of Members of M/s. Fortis Healthcare Limited ('the Company') was held on Thursday, September 26, 2019 at 12:00 Noon (IST) at the National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali, Punjab - 160062. Mr. Ravi Rajagopal, Chairman of the Company, chaired the meeting. He introduced other directors/ officials on dais. The requisite quorum being present, Chairman called the meeting to order. The Chairman delivered introductory remarks on performance of the Company. The Chairman then informed that the Company had provided the Members facility to cast their vote electronically, on all resolutions set forth in Notice dated August 6, 2019. Members who were present at the AGM and had not cast their votes electronically were provided an opportunity to cast their votes at the end the meeting. It was further informed that there would be no voting by show of hands. Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that Fortis Healthcare Limited ('the Company') received, yesterday i.e. on September 13, 2019, updates on credit ratings by 'ICRA Limited' in respect of the Company and subsidiaries of the Company viz. 1. Escorts Heart Institute and Research Centre Limited; and 2. Fortis Hospitals Limited. The relevant reports, made by ICRA Limited for such updates on credit ratings, are attached herewith. This is for your information and records please. Fortis Malar Board reclassifies Singh brothers' trust as shareholders
Fortis Hospitals Ltd, which has not been under this list, holds around 62 per cent shares in the company, till the end of June, this year Fortis Malar Board reclassifies Singh brothers' trust as shareholders
Fortis Hospitals Ltd, which has not been under this list, holds around 62 per cent shares in the company, till the end of June, this year FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Credit Rating
With reference to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, it is hereby informed that the Company received, yesterday i.e. on September 10, 2019, updates on credit rating by 'ICRA Limited' in respect of one of the subsidiaries of the Company i.e. Hiranandani Healthcare Private Limited. The relevant report made by ICRA Limited for such updates on credit rating is attached herewith. This is for your information and records please.